1-7 of 7
Eric M. Ammann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Light-Chain Amyloidosis in Sweden (2011-2019): Incidence, Disease Burden, and Clinical Outcomes in Real-World Patients

Ulf-Henrik Mellqvist, Qian Cai, Laura L Hester, Michael Grövdal, Jakob Börsum, Iffat Rahman, Eric M. Ammann, Markus Hansson
Journal: Blood
Blood (2022) 140 (Supplement 1): 5230–5231.
https://doi.org/10.1182/blood-2022-158629
Published: 2022
Journal Articles

Post-Hoc Analysis of Efficacy and Safety in the SWOG S0777 Trial Stratified By Age

Brian G.M. Durie, Annette Lam, Mai Ngo, Huiling Pei, Eric M. Ammann
Journal: Blood
Blood (2022) 140 (Supplement 1): 10009–10010.
https://doi.org/10.1182/blood-2022-165591
Published: 2022
Journal Articles

Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review

Rafael Fonseca, Diana Tran, Emily Rosta, Alyshia Laidlaw, Manvir Rai, Joana Duran, Eric M. Ammann
Journal: Blood
Blood (2022) 140 (Supplement 1): 5212–5213.
https://doi.org/10.1182/blood-2022-165569
Published: 2022
Journal Articles

First-Line Use of Daratumumab, Lenalidomide, and Dexamethasone Confers Survival Benefit Compared with Second-Line Use of Daratumumab-Based Regimens in Transplant-Ineligible Patients with Multiple Myeloma: Analysis of Different Clinical Scenarios

Rafael Fonseca, Thierry Facon, Mahmoud Hashim, Sandhya Nair, Jianming He, Eric M. Ammann, Annette Lam, Mark Wildgust, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 118.
https://doi.org/10.1182/blood-2021-144914
Published: 2021
Journal Articles

Use of Anti-Infective Prophylaxis in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma Patients Initiating Treatment with Daratumumab

Ming-Hui Tai, PhD, Eric M. Ammann, PhD, Shuchita Kaila, PhD, Christopher Pericone, Ajaybir Singh, Thomas S. Lin, MD PhD, Faith E. Davies
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-134086
Published: 2020
Journal Articles

Real-World Use of Maintenance Therapy and Associated Outcomes Following Autologous Stem Cell Transplant in US Patients with Newly Diagnosed Multiple Myeloma

Eric M. Ammann, PhD, Annette Lam, MSc, Wenze Tang, MPH, Tobias Kampfenkel, MD, Mohit Sharma, Charlene Lee, MSc, Shuchita Kaila, PhD, Alex Z. Fu, PhD, Kathleen Gray, PhD, Jianming He, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-139882
Published: 2020
Journal Articles

Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy

Clinical Trials & Observations
Eric M. Ammann, Michael P. Jones, Brian K. Link, Ryan M. Carnahan, Scott K. Winiecki, James C. Torner, Bradley D. McDowell, Bruce H. Fireman, Elizabeth A. Chrischilles
Journal: Blood
Blood (2016) 127 (2): 200–207.
https://doi.org/10.1182/blood-2015-05-647552
Published: 2016
Includes: Supplemental data